Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by DJDawgon Aug 30, 2023 11:08am
449 Views
Post# 35611902

my thoughts and questions

my thoughts and questionsThe clinical data
- The overall data was what we expected. Mostly the same %'s mainly because it is hard to budge a % when you are adding 2-5 patient's to each time interval. Nice to see the wave from last time's 180 day moving into the 270 day column.
- glad to see they have teased out the optimized data from the total. While that may not be allowed by the FDA for they data submission, it would help with how data presented to a potential JV partner.
- The newest 90 day arrivals are not great but that is statistics for you. If you reach your hand into a giant jar for which 65% of jellybeans are green, you are not going to pull out 6-7 greens each time. Sometimes it will be better or worse, slightly.
- There are very few new pendings which does not surprise me. I work in a clinic that recruits for thyroid research and recruitement rates are terrible EVERY summer. Everything get bumped to Sept  or Oct.
- the optimized data set is interesting because it start with 45 patients at 90 day but only 29 have reached 450. So 16 patients are in the pipeline and not at the final timepoint. That means that the optimized data set will improve at the latter timepoints.

BTD update
- I agree with all who have posted. Nice to see clear specifics on BTD. It sounds like they are saying that the have had the pre-BTD dialog formally started with the FDA. Glad it is a dialog where they ask questions back and forth vs submit once and pray with not detail.

The share price action today and yesterday
- I have a friend who has been part of private placements before. He says that they usually have a deadline attached to them and the deadlines is always the end of the month for getting the funds to the company. I think that may be one reason that we have seen a sudden drop in these big asks of 100,000 or 200,000 shares at 0.25. Those lucky accredited investors have played the game and gotten what funds that they can cycle out and are now on the way to getting shares and warrants.
- if I'm right that the PP has happened then I bet that there will an announcement about the PP in next few weeks.

My questions
- can those who read financials (I can't) tell me how the monthly cash burn is looking. Would be nice to know how long they have on current cash?
<< Previous
Bullboard Posts
Next >>